Berliner Boersenzeitung - New US strategy to make monkeypox vaccine go further

EUR -
AED 4.232402
AFN 72.605135
ALL 95.706558
AMD 435.177963
ANG 2.062997
AOA 1056.804427
ARS 1603.618324
AUD 1.65557
AWG 2.077307
AZN 1.961597
BAM 1.95077
BBD 2.324606
BDT 141.624843
BGN 1.969908
BHD 0.435258
BIF 3416.39138
BMD 1.152459
BND 1.476094
BOB 7.975333
BRL 6.158091
BSD 1.154224
BTN 107.90279
BWP 15.738898
BYN 3.501695
BYR 22588.187959
BZD 2.321315
CAD 1.583305
CDF 2621.843157
CHF 0.911981
CLF 0.027088
CLP 1069.589781
CNY 7.936286
CNH 7.966405
COP 4260.1092
CRC 539.109991
CUC 1.152459
CUP 30.540152
CVE 109.98143
CZK 24.533526
DJF 205.530073
DKK 7.471942
DOP 68.513349
DZD 152.623121
EGP 60.197142
ERN 17.286879
ETB 181.899523
FJD 2.566755
FKP 0.863792
GBP 0.866148
GEL 3.128882
GGP 0.863792
GHS 12.58156
GIP 0.863792
GMD 84.702925
GNF 10116.915147
GTQ 8.841204
GYD 241.474254
HKD 9.021578
HNL 30.55076
HRK 7.529019
HTG 151.419589
HUF 394.161555
IDR 19583.728468
ILS 3.618257
IMP 0.863792
INR 108.26023
IQD 1512.001545
IRR 1516203.305264
ISK 143.803546
JEP 0.863792
JMD 181.335602
JOD 0.817081
JPY 183.766402
KES 149.356508
KGS 100.780082
KHR 4612.108414
KMF 492.099875
KPW 1037.217292
KRW 1743.629507
KWD 0.353563
KYD 0.96182
KZT 554.899281
LAK 24784.881075
LBP 103366.389324
LKR 360.048548
LRD 211.215415
LSL 19.47033
LTL 3.402911
LVL 0.69711
LYD 7.388949
MAD 10.785152
MDL 20.100001
MGA 4812.737286
MKD 61.570546
MMK 2419.531945
MNT 4110.76234
MOP 9.316479
MRU 46.201876
MUR 53.67017
MVR 17.817413
MWK 2001.500236
MXN 20.76932
MYR 4.540115
MZN 73.641731
NAD 19.470498
NGN 1570.755077
NIO 42.470497
NOK 11.143238
NPR 172.643369
NZD 1.989414
OMR 0.443096
PAB 1.154209
PEN 3.990411
PGK 4.982154
PHP 69.481575
PKR 322.260089
PLN 4.284921
PYG 7538.563017
QAR 4.220618
RON 5.096631
RSD 117.502393
RUB 94.692921
RWF 1679.399082
SAR 4.327407
SBD 9.279205
SCR 16.048454
SDG 692.627514
SEK 10.871545
SGD 1.480137
SHP 0.864642
SLE 28.321615
SLL 24166.492445
SOS 659.610746
SRD 43.202787
STD 23853.56558
STN 24.436993
SVC 10.098961
SYP 127.420483
SZL 19.477457
THB 37.970631
TJS 11.085917
TMT 4.04513
TND 3.408811
TOP 2.774843
TRY 51.089066
TTD 7.830742
TWD 36.992194
TZS 2990.629888
UAH 50.564363
UGX 4362.751341
USD 1.152459
UYU 46.509075
UZS 14071.718318
VES 524.012113
VND 30356.911174
VUV 137.403135
WST 3.143667
XAF 654.281394
XAG 0.018012
XAU 0.000271
XCD 3.114577
XCG 2.080119
XDR 0.813727
XOF 654.270069
XPF 119.331742
YER 274.978746
ZAR 19.805113
ZMK 10373.512186
ZMW 22.535895
ZWL 371.091189
  • CMSC

    -0.2000

    22.65

    -0.88%

  • CMSD

    -0.2420

    22.658

    -1.07%

  • GSK

    -0.5300

    51.84

    -1.02%

  • RIO

    -2.5000

    83.15

    -3.01%

  • NGG

    -3.5400

    81.99

    -4.32%

  • AZN

    -5.3300

    183.6

    -2.9%

  • BP

    -1.0800

    44.78

    -2.41%

  • RBGPF

    -13.5000

    69

    -19.57%

  • BCC

    -1.5600

    68.3

    -2.28%

  • BCE

    0.0600

    25.79

    +0.23%

  • BTI

    -1.3500

    57.37

    -2.35%

  • RYCEF

    -1.2600

    15.34

    -8.21%

  • JRI

    -0.3900

    11.77

    -3.31%

  • VOD

    -0.0900

    14.33

    -0.63%

  • RELX

    -0.4600

    33.36

    -1.38%

New US strategy to make monkeypox vaccine go further
New US strategy to make monkeypox vaccine go further / Photo: Patrick T. FALLON - AFP

New US strategy to make monkeypox vaccine go further

US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.

Text size:

The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.

For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.

The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.

Two injections, four weeks apart, will still be necessary.

The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.

At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.

Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.

The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.

The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.

For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.

"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.

The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.

(K.Lüdke--BBZ)